Division of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, Pennsylvania 15224, USA.
Gastroenterology. 2010 Jan;138(1):185-96. doi: 10.1053/j.gastro.2009.09.045. Epub 2009 Sep 26.
BACKGROUND & AIMS: Necrotizing enterocolitis (NEC), the leading cause of gastrointestinal death from gastrointestinal disease in preterm infants, is characterized by exaggerated TLR4 signaling and decreased enterocyte proliferation through unknown mechanisms. Given the importance of beta-catenin in regulating proliferation of many cell types, we hypothesize that TLR4 impairs enterocyte proliferation in NEC via impaired beta-catenin signaling.
Enterocyte proliferation was detected in IEC-6 cells or in ileum or colon from wild-type, TLR4-mutant, or TLR4(-/-) mice after induction of NEC or endotoxemia. beta-Catenin signaling was assessed by cell fractionation or immunoconfocal microscopy to detect its nuclear translocation. Activation and inhibition of beta-catenin were achieved via cDNA or small interfering RNA, respectively. TLR4 in the intestinal mucosa was inhibited with adenoviruses expressing dominant-negative TLR4.
TLR4 activation significantly impaired enterocyte proliferation in the ileum but not colon in newborn but not adult mice and in IEC-6 enterocytes. beta-Catenin activation reversed these effects in vitro. To determine the mechanisms involved, TLR4 activation phosphorylated the upstream inhibitory kinase GSK3beta, causing beta-catenin degradation. NEC in both mouse and humans was associated with decreased beta-catenin and increased mucosal GSK3beta expression. Strikingly, the inhibition of enterocyte beta-catenin signaling in NEC could be reversed, and enterocyte proliferation restored, through adenoviral-mediated inhibition of TLR4 signaling in the small intestinal mucosa.
We now report a novel pathway linking TLR4 with inhibition of beta-catenin signaling via GSK3beta activation, leading to reduced enterocyte proliferation in vitro and in vivo. These data provide additional insights into the pathogenesis of diseases of intestinal inflammation such as NEC.
坏死性小肠结肠炎(NEC)是导致早产儿胃肠道疾病死亡的主要原因,其特征是 TLR4 信号过度激活,通过未知机制导致肠上皮细胞增殖减少。鉴于β-连环蛋白在调节多种细胞类型增殖中的重要性,我们假设 TLR4 通过损害β-连环蛋白信号来损害 NEC 中的肠上皮细胞增殖。
在诱导 NEC 或内毒素血症后,通过细胞分离或免疫共聚焦显微镜检测其核易位,检测 IEC-6 细胞或野生型、TLR4 突变型或 TLR4(-/-) 小鼠的回肠或结肠中的肠上皮细胞增殖。通过 cDNA 或小干扰 RNA 分别评估β-连环蛋白信号。用表达显性负性 TLR4 的腺病毒抑制肠黏膜中的 TLR4。
TLR4 激活显著损害了新生而非成年小鼠和 IEC-6 肠上皮细胞回肠而不是结肠中的肠上皮细胞增殖。β-连环蛋白的激活在体外逆转了这些作用。为了确定所涉及的机制,TLR4 激活使上游抑制性激酶 GSK3β磷酸化,导致β-连环蛋白降解。NEC 在小鼠和人类中均与β-连环蛋白表达减少和黏膜 GSK3β表达增加有关。引人注目的是,通过腺病毒介导的小肠黏膜 TLR4 信号抑制,NEC 中肠上皮细胞β-连环蛋白信号的抑制可以逆转,并且肠上皮细胞增殖可以恢复。
我们现在报告了一种新的途径,通过 GSK3β 激活将 TLR4 与抑制β-连环蛋白信号联系起来,导致体外和体内肠上皮细胞增殖减少。这些数据为诸如 NEC 等肠道炎症性疾病的发病机制提供了更多的见解。